STAT6 and ovarian carcinoma: Moreover, miR-135a upregulation suppresses cellular proliferation and xenograft tumor growth in ovarian cancer [17], and miR-135a may also serve as a tumor suppressor in prostate cancer by inhibiting STAT6 [13].